Designing Cancer Therapeutics with AI/ML

BIOIVA Generative Therapeutics Design


Accelerate small molecule therapeutics design with AI/ML

Design and discovery of cancer therapeutics is challenging as it requires consideration of multiple critical parameters such as potency, selectivity, ADME properties, tolerability, and more.

In this collaborative project, BIOVIA partnered with a research institute to optimize leads that would meet complex target product profiles. 

Download the use case to learn how BIOVIA Generative Therapeutics Design helps customers design and optimize high-quality small molecule drug candidates faster.

Download use case now